Positron Emitting Activity [MoA]: Side Effects & Safety Data for 8 Drugs
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
Positron Emitting Activity [MoA] includes 8 drugs with a combined 693 adverse event reports in the FDA FAERS database. Compare their safety profiles, side effects, and outcomes below.
8
Drugs in Class
693
Combined Reports
All Positron Emitting Activity [MoA] Drugs Ranked by Reports
| Drug | Brand Name | Reports | Deaths | Hosp. | Death Rate |
|---|---|---|---|---|---|
| GALLIUM GA-OZETOTIDE | Gallium Ga-68 PSMA-11 | 204 | 4 | 35 | 2.0% |
| PIFLUFOLASTAT F-18 | PYLARIFY | 191 | 0 | 3 | N/A |
| FLUCICLOVINE F-18 | Axumin | 102 | 2 | 2 | 2.0% |
| FLORBETAPIR F-18 | Amyvid | 99 | 1 | 9 | 1.0% |
| COPPER OXODOTREOTIDE CU-64 | Detectnet | 47 | 0 | 1 | N/A |
| FLOTUFOLASTAT F-18 | POSLUMA | 23 | 0 | 0 | N/A |
| FLORBETABEN F-18 | Neuraceq | 16 | 0 | 2 | N/A |
| FLUOROESTRADIOL F-18 | CERIANNA | 11 | 0 | 0 | N/A |
Common Side Effects in Positron Emitting Activity [MoA] Drugs
| Side Effect | Reports | Deaths |
|---|---|---|
| Injection site pain | 93 | 0 |
| Radioisotope scan abnormal | 81 | 0 |
| Drug ineffective | 59 | 0 |
| Amyloid related imaging abnormality-oedema/effusion | 34 | 0 |
| Product dispensing error | 34 | 0 |
| No adverse event | 32 | 0 |
| Amyloid related imaging abnormality-microhaemorrhages and haemosiderin deposits | 27 | 0 |
| Positron emission tomogram abnormal | 27 | 0 |
| Therapeutic response unexpected | 20 | 0 |
| Nausea | 19 | 0 |